IRF5 and breast cancer: We identified significant differential expression of proteins in pathways constituting a variety of biological processes (Fig. 5b) and molecular functions (Fig. 5c) that support our prior findings that 4T1 IRF5-low BC is highly metastatic and t-dEVs from this cell line establish a PMN that increases metastasis.